Millions of people worldwide are affected by Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Yet the causes, diagnostic markers, progression, and FDA-approved treatments remain unknown. The shared vision of the ME/CFS Collaborative Research Network (ME/CFSnet) is to encourage collaborative research in partnership with individuals and advocacy groups to understand the disease and develop better diagnosis and treatment.
16th Invest in ME Research International ME Conference
June 28, 2024
The IIMEC16 will provide ME updates from around the world and focus on advancing understanding of ME, by bridging research and clinical treatment. Register today!
Take Me ThereInternational ME Conference Week
June 25, 2024
The 13th International Biomedical Research into ME Colloquium takes place at the Wellcome Genome Campus, UK, in June. This year's theme, Acknowledging the acceptance by both clinicians and researchers of 'THE INFECTIOUS AETIOLOGY' of ME/CFS focuses on uncovering the complexities of ME, exploring acute infection, chronic infection, and co-infection. Conference events will convene on June 25 to June 28, 2024.
Take Me ThereNINDS Director’s Message
June 3, 2024
NINDS Director, Dr. Walter Koroshetz shares an update on the ME/CFS Research Roadmap and the importance of advancing ME/CFS research.
Take Me ThereThese institutions are working together as the ME/CFS Research Network.
Visit the CDC to learn more about ME/CFS.
Investigators, health care providers, and advocates are collaborating across the Research Network to drive progress in understanding ME/CFS. Together, we can advance discoveries to improve the lives of members of the ME/CFS community.
What is ME/CFS?
Myalgic Encephalomyelitis (ME), also referred to as Chronic Fatigue Syndrome (CFS), is a multi-system disease that causes dysfunction of the neurological, immune, endocrine, and energy metabolism systems.